Hebei Bohai Bioengineering Open Co., Ltd

country:China
core technology:medical biochemistry
industry field:Other areas
release unit:河北博海生物工程开发有限公司
demand unit:Hebei Bohai Bioengineering Development Co., Ltd
cooperation mode:Project cooperation
2023-06-06 18:20:28 6
Project description
1. Continue the NMPA registration work for different specifications of analytical reading systems and convenient terminal detection devices developed by Professor George Smoot. 2. Carry out the research and development of the "breast cancer specific multi target diagnosis and treatment scheme joint research and development cooperation demonstration" project as planned, and complete the annual task goal with quality and quantity guaranteed. Further promote the cooperative research with Duke University, and promote the implementation of the "in vivo and in vitro research project of multi-target individualized treatment of triple negative breast cancer" in the United States. Detecting the types and quantities of tumor targets in the serum of healthy, high-risk, or suspected tumor patients to determine the occurrence and development of tumors is a "sharp tool" for early detection of tumors. Early detection of the focus is earlier than the clinical routine means. Through early intervention, tumor cell proliferation and tumor development can be controlled, early detection and early treatment can reduce the incidence rate of tumors to the greatest extent. Secondly, through early screening, the screening data will be summarized and analyzed to provide a more reliable data basis for the statistical work of cancer incidence rate in China. By detecting specific tumor targets in the serum of confirmed patients and customizing their own sensitive cluster targets based on the detection results, a large number of immune cells with multi target recognition and killing ability are induced and cultivated. After transfusion, precise killing of the tumor is carried out, extending the patient's survival time and improving their survival, truly achieving more targeted and personalized immunotherapy. Additionally, it can be used in combination with targeted drugs such as PD-1 and is currently undergoing preclinical research.

contact:

contact information:

company address:

Company profile:

  • 2022-11-02 18:02 *** 电话联系了该立项企业
  • 2022-11-02 18:02 *** 电话联系了该立项企业
  • 2022-11-02 18:02 *** 电话联系了该立项企业
  • 2022-11-02 18:02 *** 电话联系了该立项企业
  • 2022-11-02 18:02 *** 电话联系了该立项企业
related item
Cooperative education projects

country:No limit

release time:2023-06-06

release unit:河北寰球才智网

core technology:Cooperative education projects

demand unit:International Exchange Center of Vocational and Adult Education Research Center

cooperation mode:unlimited

participate in the project
Research and development project of inhaled drugs through the lungs

country:China

release time:2023-06-06

release unit:智库石家庄京津冀产学研数据服务有限公司

core technology:Biomedical

demand unit:Think Tank Shijiazhuang Beijing Tianjin Hebei Industry University Research Data Service Co. Ltd

cooperation mode:Project cooperation

participate in the project
Utilizing the advantages of various miscellaneous grains and combining light food culture to develop conditioned foods

country:China

release time:2023-06-06

release unit:唐山广野食品集团有限公司

core technology:Food manufacturing

demand unit:Tangshan Guangye Food Group Co. Ltd

cooperation mode:Project cooperation

participate in the project
Plastic steel strip iron crushing and separation

country:China

release time:2023-06-06

release unit:河北智皓环保机械制造有限公司

core technology:manufacturing

demand unit:Hebei Zhihao Environmental Protection Machinery Manufacturing Co. Ltd

cooperation mode:Project cooperation

participate in the project
Hebei Global Intelligence Information
X
Hello! Hebei Huanqiu Intelligence Network Customer Service Xiaohui will serve you wholeheartedly~
You can leave questions and contact information, and special personnel will contact you~
name *
telephone *
problem *
Thank you for your message~ Close the window